This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GIUDICE, L. C. Articles by ROSENFELD, R. G. Search for Related Content PubMed PubMed Citation Articles by GIUDICE, L. C. Articles by ROSENFELD, R. G.

Insulin-Like Growth Factor Binding Proteins in Maternal Serum Throughout Gestation and in the Puerperium: Effects of a Pregnancy-Associated Serum Protease Activity^*

Departments of Gynecology and Obstetrics (L.C.G., E.M.F.) and Pediatrics (H.P., G.L., R.G.R.), Stanford University Medical Center Stanford, California 94305

Address all correspondence and requests for reprints to: Dr. Linda C. Giudice, Stanford University Medical Center, Boswell Building, A342, Stanford, California 94305.

The cDNAs encoding three major insulin-like growth factor-binding proteins (IGFBPs) have been cloned and sequenced. We have examined, by Western ligand blotting, the profiles of these binding proteins in human female serum in the normal menstrual cycle, throughout pregnancy, and during the postpartum period. There was no change in the serum profile of any of the binding proteins in early pregnancy compared to that in the secretory phase of the menstrual cycle. However, there was a marked decrease in circulating levels of the main serum IGFBP, IGFBP-3, after 6 weeks of gestation, continuing progressively to term and returning to nonpregnant levels by 5 days postpartum. IGFBP-2 decreased steadily throughout gestation. In contrast, IGFBP-1 levels were found to rise by the second trimester. Endoglycosidase-F digestion did not enhance detection of IGFBP-3 by ligand blotting. Immunoprecipitations with two separate antibodies against IGFBP-3 and IGFBP-2, followed by Western ligand blotting, confirmed the marked decrease in IGFBP-3 levels after 6 weeks of gestation and the more gradual decrease in IGFBP-2. In contrast, immunoprecipitations with IGFBP-1 monoclonal antibodies confirmed the increase in IGFBP-1 during gestation. Endogenous serum IGFs were separated from serum IGFBPs by acid chromatography, and an 80° decrease in total IGF-binding activity in the IGFBP fraction of chromatographed pregnancy us. nonpregnancy serum was detected by charcoal absorption assay. Furthermore, immunoprecipitations of IGF affinity cross-linked IGFBP fractions with IGFBP-3-specific antiserum confirmed a marked diminution of IGFBP-3 in pregnancy compared to nonpregnancy serum, and revealed, only in pregnancy serum, the concomitant appearance of a band with a mol wt of 34K and three less intense bands with mol wt between 20–26K on sodium dodecyl sulfate gels. Incubation of nonpregnancy serum with 6-week pregnancy serum at 37 C for 5 h, followed by Western ligand blotting, showed only a slight reduction in the amount of IGFBP-3 in the mixture compared to that in controls. However, incubation of term pregnancy with nonpregnancy serum at 37 C for 5 h revealed a marked reduction of IGFBP-3 in the mixture. When iodinated recombinant IGFBP-3 was incubated with term pregnancy serum under the same conditions, the appearance of a 29K protein was identified by gel electrophoresis and autoradiography, along with three less intense bands with mol wt between 17–22K. Taken together, the data demonstrate that the main circulating serum IGFBP in the nonpregnant state, IGFBP-3, is markedly reduced during pregnancy, and its reduction may be due to an endogenous pregnancy-related serum protease. Another major serum IGFBP, IGFBP-2, also decreases during pregnancy, and its reduction apparently may also be related to a pregnancy-related protease. IGFBP-1, on the other hand, increases throughout gestation.

^* This work was supported in part by the Katherine McCormick Fund (to L.C.G.), NIH Biomedical Research Support Grant 2S07-RR-05353-27 (to L.C.G.), and NIH Grant DK-28229 (to R.G.R.).

Received January 5, 1989.

This article has been cited by other articles:

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, and C. Y. Bowers Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition Endocr. Rev., April 1, 2006; 27(2): 101 - 140. [Abstract] [Full Text] [PDF]

				D. R. Clemmons, M. Sleevi, and W. H. Busby Jr. Recombinant, Nonglycosylated Human Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) Is Degraded Preferentially after Administration to Type II Diabetics, Resulting in Increased Endogenous Glycosylated IGFBP-3 J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6561 - 6568. [Abstract] [Full Text] [PDF]

				D. K. Tisi, X.-J. Liu, L. J. Wykes, C. D. Skinner, and K. G. Koski Insulin-Like Growth Factor II and Binding Proteins 1 and 3 from Second Trimester Human Amniotic Fluid Are Associated with Infant Birth Weight J. Nutr., July 1, 2005; 135(7): 1667 - 1672. [Abstract] [Full Text] [PDF]

				L. D. Payet, S. M. Firth, and R. C. Baxter The Role of the Acid-Labile Subunit in Regulating Insulin-Like Growth Factor Transport across Human Umbilical Vein Endothelial Cell Monolayers J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2382 - 2389. [Abstract] [Full Text] [PDF]

				M. Chellakooty, K. Vangsgaard, T. Larsen, T. Scheike, J. Falck-Larsen, J. Legarth, A. M. Andersson, K. M. Main, N. E. Skakkebaek, and A. Juul A Longitudinal Study of Intrauterine Growth and the Placental Growth Hormone (GH)-Insulin-Like Growth Factor I Axis in Maternal Circulation: Association between Placental GH and Fetal Growth J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 384 - 391. [Abstract] [Full Text] [PDF]

				H. Norrelund, J. Frystyk, J. O. L. Jorgensen, N. Moller, J. S. Christiansen, H. Orskov, and A. Flyvbjerg The Effect of Growth Hormone on the Insulin-Like Growth Factor System during Fasting J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3292 - 3298. [Abstract] [Full Text] [PDF]

				I. Y. C. Sun, M. T. Overgaard, C. Oxvig, and L. C. Giudice Pregnancy-Associated Plasma Protein A Proteolytic Activity Is Associated with the Human Placental Trophoblast Cell Membrane J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5235 - 5240. [Abstract] [Full Text] [PDF]

				L. C. Giudice, C. A. Conover, L. Bale, G. H. Faessen, K. Ilg, I. Sun, B. Imani, L.-F. Suen, J. C. Irwin, M. Christiansen, et al. Identification and Regulation of the IGFBP-4 Protease and Its Physiological Inhibitor in Human Trophoblasts and Endometrial Stroma: Evidence for Paracrine Regulation of IGF-II Bioavailability in the Placental Bed during Human Implantation J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2359 - 2366. [Abstract] [Full Text] [PDF]

				P. Vorwerk, B. Hohmann, Y. Oh, R. G. Rosenfeld, and R. M. Shymko Binding Properties of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3), IGFBP-3 N- and C-Terminal Fragments, and Structurally Related Proteins mac25 and Connective Tissue Growth Factor Measured Using a Biosensor Endocrinology, May 1, 2002; 143(5): 1677 - 1685. [Abstract] [Full Text] [PDF]

				D. R. Clemmons Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships Endocr. Rev., December 1, 2001; 22(6): 800 - 817. [Abstract] [Full Text] [PDF]

				R. C. Baxter What Is the Significance of IGF-Binding Protein-3 Proteolysis in the Circulation? J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5087 - 5088. [Full Text] [PDF]

				M. Binoux Tools Now Exist to Measure Circulating IGF-Binding Protein-3 Proteolysis, to Study Its Regulation and Its Effects on IGF-I Bioavailability J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5088 - 5089. [Full Text] [PDF]

				J. Nygren, C. Carlsson-Skwirut, K. Brismar, A. Thorell, O. Ljungqvist, and P. Bang Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E736 - E741. [Abstract] [Full Text] [PDF]

				C. Lassarre, F. Duron, and M. Binoux Use of the Ligand Immunofunctional Assay for Human Insulin-Like Growth Factor (IGF) Binding Protein-3 (IGFBP-3) to Analyze IGFBP-3 Proteolysis and IGF-I Bioavailability in Healthy Adults, GH-Deficient and Acromegalic Patients, and Diabetics J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1942 - 1952. [Abstract] [Full Text]

				C. LASSARRE and M. BINOUX Measurement of Intact Insulin-Like Growth Factor-Binding Protein-3 in Human Plasma Using a Ligand Immunofunctional Assay J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1260 - 1266. [Abstract] [Full Text]

				D. Byun, S. Mohan, M. Yoo, C. Sexton, D. J. Baylink, and X. Qin Pregnancy-Associated Plasma Protein-A Accounts for the Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Proteolytic Activity in Human Pregnancy Serum and Enhances the Mitogenic Activity of IGF by Degrading IGFBP-4 in Vitro J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 847 - 854. [Abstract] [Full Text]

				S. I. Helle, T. Ueland, D. Ekse, S. S. Frøland, J. M. P. Holly, P. E. Lønning, and P. Aukrust The Insulin-Like Growth Factor System in Human Immunodeficiency Virus Infection: Relations to Immunological Parameters, Disease Progression, and Antiretroviral Therapy J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 227 - 233. [Abstract] [Full Text]

				A. Diamandi, J. Mistry, R. G. Krishna, and J. Khosravi Immunoassay of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3): New Means to Quantifying IGFBP-3 Proteolysis J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2327 - 2333. [Abstract] [Full Text]

				J. C. Irwin, L.-F. Suen, B.-H. Cheng, R. Martin, P. Cannon, C. L. Deal, and L. C. Giudice Human Placental Trophoblasts Secrete a Disintegrin Metalloproteinase Very Similar to the Insulin-Like Growth Factor Binding Protein-3 Protease in Human Pregnancy Serum Endocrinology, February 1, 2000; 141(2): 666 - 674. [Abstract] [Full Text] [PDF]

				D. Byun, S. Mohan, C. Kim, K. Suh, M. Yoo, H. Lee, D. J. Baylink, and X. Qin Studies on Human Pregnancy-Induced Insulin-Like Growth Factor (IGF)-Binding Protein-4 Proteases in Serum: Determination of IGF-II Dependency and Localization of Cleavage Site J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 373 - 381. [Abstract] [Full Text]

				V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text]

				R. G. Rosenfeld, V. Hwa, L. Wilson, A. Lopez-Bermejo, C. Buckway, C. Burren, W. K. Choi, G. Devi, A. Ingermann, D. Graham, et al. The Insulin-like Growth Factor Binding Protein Superfamily: New Perspectives Pediatrics, October 1, 1999; 104(4): 1018 - 1021. [Abstract] [Full Text]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				R.P. Holmes, J.M.P. Holly, and P.W. Soothill Maternal serum insulin-like growth factor binding protein-2 and -3 and fetal growth Hum. Reprod., July 1, 1999; 14(7): 1879 - 1884. [Abstract] [Full Text] [PDF]

				A. Iranmanesh, T. Mulligan, and J. D. Veldhuis Mechanisms Subserving the Physiological Nocturnal Relative Hypoprolactinemia of Healthy Older Men: Dual Decline in Prolactin Secretory Burst Mass and Basal Release with Preservation of Pulse Duration, Frequency, and Interpulse Interval--A General Clinical Research Center Study J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1083 - 1090. [Abstract] [Full Text]

				Christine P. Burren, E. M. Wilson, V. Hwa, Y. Oh, and R. G. Rosenfeld Binding Properties and Distribution of Insulin-Like Growth Factor Binding Protein-Related Protein 3 (IGFBP-rP3/NovH), an Additional Member of the IGFBP Superfamily J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1096 - 1103. [Abstract] [Full Text]

				S. L. Bradshaw, A. J. D’Ercole, and V. K. M. Han Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in C6 Glioma Cells Results in Conditional Alteration of Cellular Growth Endocrinology, February 1, 1999; 140(2): 575 - 584. [Abstract] [Full Text]

				L. A. Maile, S. Xu, S. C. Cwyfan-Hughes, J. K. Fernihough, J. M. Pell, and J. M. P. Holly Active and Inhibitory Components of the Insulin-Like Growth Factor Binding Protein-3 Protease System in Adult Serum, Interstitial, and Synovial Fluid Endocrinology, December 1, 1998; 139(12): 4772 - 4781. [Abstract] [Full Text] [PDF]

				A. Parker, C. Rees, J. Clarke, W. H. Busby Jr., and D. R. Clemmons Binding of Insulin-like Growth Factor (IGF)-Binding Protein-5 to Smooth-Muscle Cell Extracellular Matrix Is a Major Determinant of the Cellular Response to IGF-I Mol. Biol. Cell, September 1, 1998; 9(9): 2383 - 2392. [Abstract] [Full Text]

				J. T. Allen, C. A. Bloor, R. A. Knight, and M. A. Spiteri Expression of Insulin-like Growth Factor Binding Proteins in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 250 - 258. [Abstract] [Full Text]

				C. Skjærbæk, J. Frystyk, H. Ørskov, P. Kissmeyer-Nielsen, M. B. Jensen, S. Laurberg, N. Møller, and A. Flyvbjerg Differential Changes in Free and Total Insulin-Like Growth Factor I after Major, Elective Abdominal Surgery: The Possible Role of Insulin-Like Growth Factor-Binding Protein-3 Proteolysis J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2445 - 2449. [Abstract] [Full Text]

				P. Bang, J. Nygren, C. Carlsson-Skwirut, A. Thorell, and O. Ljungqvist Postoperative Induction of Insulin-Like Growth Factor Binding Protein-3 Proteolytic Activity: Relation to Insulin and Insulin Sensitivity J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2509 - 2515. [Abstract] [Full Text]

				A. Eliakim, J. A. Brasel, S. Mohan, W. L. T. Wong, and D. M. Cooper Increased physical activity and the growth hormone-IGF-I axis in adolescent males Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R308 - R314. [Abstract] [Full Text] [PDF]

				D. R. Powell, S. K. Durham, F. Liu, B. K. Baker, P. D. K. Lee, S. L. Watkins, P. G. Campbell, E. D. Brewer, R. L. Hintz, and R. J. Hogg The Insulin-Like Growth Factor Axis and Growth in Children with Chronic Renal Failure: A Report of the Southwest Pediatric Nephrology Study Group J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1654 - 1661. [Abstract] [Full Text]

				C. Skjærbæk, A. Kaal, J. Møller, N. Vahl, J. Weeke, H. Ørskov, and A. Flyvbjerg No Effect of Growth Hormone on Serum Insulin-Like Growth Factor Binding Protein-3 Proteolysis J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1206 - 1210. [Abstract] [Full Text]

				B. Kubler, S. Cowell, J. Zapf, and T. Braulke Proteolysis of Insulin-Like Growth Factor Binding Proteins by a Novel 50-Kilodalton Metalloproteinase in Human Pregnancy Serum Endocrinology, April 1, 1998; 139(4): 1556 - 1563. [Abstract] [Full Text] [PDF]

				B. E. Forbes, D. Turner, S. J. Hodge, K. A. McNeil, G. Forsberg, and J. C. Wallace Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain J. Biol. Chem., February 20, 1998; 273(8): 4647 - 4652. [Abstract] [Full Text] [PDF]

				Y. Yamanaka, E. M. Wilson, R. G. Rosenfeld, and Y. Oh Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins J. Biol. Chem., December 5, 1997; 272(49): 30729 - 30734. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				P. Bang and P. J. Fielder Human Pregnancy Serum Contains at Least Two Distinct Proteolytic Activities with the Ability To Degrade Insulin-Like Growth Factor Binding Protein-3 Endocrinology, September 1, 1997; 138(9): 3912 - 3917. [Abstract] [Full Text] [PDF]

				H. Salahifar, R. C. Baxter, and J. L. Martin Insulin-like Growth Factor Binding Protein (IGFBP)-3 Protease Activity Secreted by MCF-7 Breast Cancer Cells: Inhibition by IGFs Does Not Require IGF-IGFBP Interaction Endocrinology, April 1, 1997; 138(4): 1683 - 1690. [Abstract] [Full Text] [PDF]

				M. Westwood, J M. Gibson, and A. White Purification and Characterization of the Insulin-Like Growth Factor-Binding Protein-1 Phosphoform Found in Normal Plasma Endocrinology, March 1, 1997; 138(3): 1130 - 1136. [Abstract] [Full Text] [PDF]

				J. L. Stock, M. R. Warth, B. T. Teh, J. A. Coderre, J. H. Overdorf, G. Baumann, R. L. Hintz, M. L. Hartman, B. R. Seizinger, C. Larsson, et al. A Kindred with a Variant of Multiple Endocrine Neoplasia Type 1 Demonstrating Frequent Expression of Pituitary Tumors but Not Linked to the Multiple Endocrine Neoplasia Type 1 Locus at Chromosome Region 11q13 J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 486 - 492. [Abstract] [Full Text] [PDF]

				G. Radetti, M. Bozzola, C. Paganini, R. Valentini, L. Gentili, K. Tettoni, and L. Tato Growth Hormone Bioactivity and Levels of Growth Hormone, Growth Hormone-Binding Protein, Insulinlike Growth Factor I, and Insulinlike Growth Factor-Binding Proteins in Premature and Full-term Newborns During the First Month of Life Arch Pediatr Adolesc Med, February 1, 1997; 151(2): 170 - 175. [Abstract] [PDF]

				Y. Hasegawa, T. Hasegawa, K. Fujii, H. Konii, M. Anzo, T. Aso, S. Koto, M. Takada, and Y. Tsuchiya High Ratios of Free to Total Insulin-Like Growth Factor-I in Early Infancy J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 156 - 158. [Abstract] [Full Text] [PDF]

				J. P. Miell, K. S. Langford, J. S. Jones, P. Noble, M. Westwood, A. White, and K. H. Nicolaides The Maternal Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Response to Trisomic Pregnancy during the First Trimester: A Possible Diagnostic Tool for Trisomy 18 Pregnancies J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 287 - 292. [Abstract] [Full Text] [PDF]

				Y. Oh, S. R. Nagalla, Y. Yamanaka, H.-S. Kim, E. Wilson, and R. G. Rosenfeld Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7. RECOMBINANT HUMAN mac25 PROTEIN SPECIFICALLY BINDS IGF-I AND -II J. Biol. Chem., November 29, 1996; 271(48): 30322 - 30325. [Abstract] [Full Text] [PDF]